Anneli Elme
Anneli Elme publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Surgery, on topics such as Gastric Cancer Management and Outcomes, Colorectal Cancer Treatments and Studies and Esophageal Cancer Research and Treatment.
- World rank
- #299,291 of 7,710,434 ranked researchers
- Rank in Estonia
- #287 of 4,874
- Works
- 39
- Citations
- 3.3k
- Citations per work
- 85.1
What does Anneli Elme research?
Anneli Elme's work is mostly in Medicine (86%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3385.8%
- Medicine3385.8%
- Everything else614.2%
- 1Oncology37% of their works
- 2Pulmonary and Respiratory Medicine23% of their works
- 3Surgery13% of their works
- 4Gastroenterology5% of their works
- 5Physiology4% of their works
- 6Otorhinolaryngology4% of their works
Research topics
- Gastric Cancer Management and Outcomes
- Colorectal Cancer Treatments and Studies
- Esophageal Cancer Research and Treatment
- Gastrointestinal Tumor Research and Treatment
- Cancer survivorship and care
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Surgical Treatments
- Pancreatic and Hepatic Oncology Research
Which keywords describe Anneli Elme's research?
The keywords of their largest research topics: Chemotherapy, Endoscopic Resection, Clinical Practice Guidelines, Neoadjuvant Therapy, Gastric Cancer, Molecular Characterization, Preoperative Chemoradiotherapy and Barrett's Esophagus.
- Surgical Complications
- Rectal Cancer
- Immune Checkpoint Blockade
- Sunitinib
- Imatinib Mesylate
- Tumor Microenvironment
- Esophageal Carcinoma
- Barrett's Esophagus
- Molecular Characterization
- Neoadjuvant Therapy
- Endoscopic Resection
- Chemotherapy
- Clinical Practice Guidelines
- Gastric Cancer
- Preoperative Chemoradiotherapy
- Cetuximab
- KRAS Mutations
- Cancer Survivorship
- Quality of Life
- Adjuvant Chemotherapy
- PD-1 and PD-L1
- Pancreatic Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Chemotherapy323 topics
- Endoscopic Resection282 topics
- Clinical Practice Guidelines232 topics
- Neoadjuvant Therapy193 topics
- Gastric Cancer181 topic
- Molecular Characterization181 topic
- Preoperative Chemoradiotherapy152 topics
- Barrett's Esophagus101 topic
- Cetuximab101 topic
- Esophageal Carcinoma101 topic
- KRAS Mutations101 topic
- Tumor Microenvironment92 topics
- Cancer Survivorship61 topic
- Imatinib Mesylate61 topic
- Quality of Life61 topic
- Sunitinib61 topic
- Adjuvant Chemotherapy51 topic
- Immune Checkpoint Blockade51 topic
- PD-1 and PD-L151 topic
- Rectal Cancer51 topic
- Pancreatic Cancer41 topic
- Surgical Complications41 topic
Where does Anneli Elme work?
Anneli Elme's main affiliation in the publication record is North Estonia Medical Centre, Estonia.
How many publications and citations does Anneli Elme have?
OpenAlex counts 39 works and 3,320 citations for Anneli Elme, an h-index of 20, ranking #299,291 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Anneli Elme. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.